{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:13:52Z","timestamp":1794356032136,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023Y9408"],"award-info":[{"award-number":["2023Y9408"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025Y9675"],"award-info":[{"award-number":["2025Y9675"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J011271"],"award-info":[{"award-number":["2023J011271"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.radonc.2026.111366","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:44:45Z","timestamp":1767631485000},"page":"111366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A seven-gene 5-hydroxymethylcytosine signature in circulating cell-free DNA for prognostic stratification of nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-7220","authenticated-orcid":false,"given":"Bijuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianji","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouwei","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111366_b0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110613","article-title":"Long-term trends in the burden of nasopharyngeal carcinoma in China: a comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021","volume":"202","author":"Chen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104513","article-title":"Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: a systematic review","volume":"10","author":"Blanchard","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.radonc.2026.111366_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111366_b0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.annonc.2020.03.289","article-title":"Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy","volume":"31","author":"Hui","year":"2020","journal-title":"Ann Oncol: Off J European Soc Med Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0035","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1007\/s00405-024-08714-w","article-title":"Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma","volume":"281","author":"Liu","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2026.111366_b0040","first-page":"5805","article-title":"MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives","volume":"13","author":"Chen","year":"2023","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.radonc.2026.111366_b0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12935-023-03074-7","article-title":"Methylomics and cancer: the current state of methylation profiling and marker development for clinical care","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.radonc.2026.111366_b0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40364-025-00751-9","article-title":"5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation","volume":"13","author":"Song","year":"2025","journal-title":"Biomarker Res"},{"key":"10.1016\/j.radonc.2026.111366_b0055","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/nchem.2064","article-title":"5-Hydroxymethylcytosine is a predominantly stable DNA modification","volume":"6","author":"Bachman","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.radonc.2026.111366_b0060","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/nprot.2012.137","article-title":"Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine","volume":"7","author":"Yu","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.radonc.2026.111366_b0065","doi-asserted-by":"crossref","unstructured":"Kroeze LI, van der Reijden BA, Jansen JH. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2015;1855:144-54.","DOI":"10.1016\/j.bbcan.2015.01.001"},{"key":"10.1016\/j.radonc.2026.111366_b0070","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-24-0199","article-title":"A 5-Hydroxymethylcytosine-based noninvasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 study","volume":"30","author":"Chang","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111366_b0075","article-title":"5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma. European journal of cancer (Oxford","volume":"2024","author":"Chen","year":"1990","journal-title":"England"},{"key":"10.1016\/j.radonc.2026.111366_b0080","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","article-title":"Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma","volume":"68","author":"Cai","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2026.111366_b0085","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/bloodadvances.2019000175","article-title":"Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma","volume":"3","author":"Chiu","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2026.111366_b0090","article-title":"An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas","volume":"3","author":"Cai","year":"2021","journal-title":"Neuro-Oncol Adv"},{"key":"10.1016\/j.radonc.2026.111366_b0095","article-title":"5-Hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma","volume":"8","author":"Chennakesavalu","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0100","article-title":"Cell-free DNA 5-hydroxymethylcytosine signatures for lung cancer prognosis","volume":"13","author":"Shao","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2026.111366_b0105","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s10565-023-09830-9","article-title":"Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer","volume":"39","author":"Looi","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.radonc.2026.111366_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166838","article-title":"Epigenetics of epstein barr virus \u2014 a review","volume":"1869","author":"Shareena","year":"2023","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.radonc.2026.111366_b0115","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/cr.2017.121","article-title":"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.radonc.2026.111366_b0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","article-title":"Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer","volume":"559","author":"Wu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2026.111366_b0125","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA: a cancer journal for clinicians. 2017;67:93-9.","DOI":"10.3322\/caac.21388"},{"key":"10.1016\/j.radonc.2026.111366_b0130","doi-asserted-by":"crossref","unstructured":"Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. 2019;68:2195-205.","DOI":"10.1136\/gutjnl-2019-318882"},{"key":"10.1016\/j.radonc.2026.111366_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt.1732","article-title":"Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine","volume":"29","author":"Song","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.radonc.2026.111366_b0140","first-page":"139","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.radonc.2026.111366_b0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2020.12.035","article-title":"Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: a prospective observation series","volume":"156","author":"Guo","year":"2021","journal-title":"Radiother Oncol: J European Soc Therapeutic Radiol Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-022-02648-4","article-title":"Exaggerated false positives by popular differential expression methods when analyzing human population samples","volume":"23","author":"Li","year":"2022","journal-title":"Genome Biol"},{"key":"10.1016\/j.radonc.2026.111366_b0155","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Cambridge (Mass))"},{"key":"10.1016\/j.radonc.2026.111366_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.radonc.2026.111366_b0165","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111366_b0170","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2026.111366_b0175","article-title":"Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA","volume":"16","author":"Weng","year":"2024","journal-title":"Therapeutic Adv Med Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0180","article-title":"Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases","volume":"13","author":"Chen","year":"2021","journal-title":"Therapeutic Adv Med Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0185","doi-asserted-by":"crossref","unstructured":"Yin H, Zhang M, Zhang Y, Zhang X, Zhang X, Zhang B. Liquid biopsies in cancer. Molecular biomedicine. 2025;6:18.","DOI":"10.1186\/s43556-025-00257-8"},{"key":"10.1016\/j.radonc.2026.111366_b0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.radonc.2026.111366_b0195","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/cr.2017.106","article-title":"5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages","volume":"27","author":"Song","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.radonc.2026.111366_b0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13148-023-01547-0","article-title":"Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia","volume":"15","author":"Shao","year":"2023","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.radonc.2026.111366_b0205","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1038\/s41598-022-16685-3","article-title":"Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia","volume":"12","author":"Shao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111366_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.radonc.2026.111366_b0215","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2026.111366_b0220","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1007\/s11033-023-08675-z","article-title":"Overexpression of ferritin light chain as a poor prognostic factor for breast cancer","volume":"50","author":"Tang","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.radonc.2026.111366_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235504","article-title":"Hemoglobin subunit theta 1 promotes proliferation by reducing reactive oxygen species in lung adenocarcinoma","author":"Kim","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2026.111366_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells14171314","article-title":"Calpain-1 and calpain-2 promote breast cancer metastasis","volume":"14","author":"Harper","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2026.111366_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105853","article-title":"Deciphering the molecular landscape of the FAM72 gene family: Implications for stem cell biology and cancer","volume":"180","author":"Ramesh","year":"2024","journal-title":"Neurochem Int"},{"key":"10.1016\/j.radonc.2026.111366_b0240","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1186\/s12885-025-14935-x","article-title":"C1QTNF1-AS1\/miR-346 axis suppresses osteosarcoma progression via dual inhibition of LDHA\/PDK1-mediated Warburg effect","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2026.111366_b0245","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41418-024-01430-2","article-title":"Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival","volume":"32","author":"De Palma","year":"2025","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.radonc.2026.111366_b0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.radonc.2026.111366_b0255","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41392-023-01537-x","article-title":"TET (Ten-eleven translocation) family proteins: structure, biological functions and applications","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.radonc.2026.111366_b0260","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygeno.2014.08.017","article-title":"Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence?","volume":"104","author":"Ficz","year":"2014","journal-title":"Genomics"},{"key":"10.1016\/j.radonc.2026.111366_b0265","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2025.2473250","article-title":"TET-mediated 5hmC in breast cancer: mechanism and clinical potential","volume":"20","author":"Zhang","year":"2025","journal-title":"Epigenetics"},{"key":"10.1016\/j.radonc.2026.111366_b0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.trecan.2020.12.011","article-title":"Roles and regulations of TET Enzymes in solid tumors","volume":"7","author":"Bray","year":"2021","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.radonc.2026.111366_b0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcancer.2019.04.001","article-title":"Emerging role of PI3K\/AKT in tumor-related epigenetic regulation","volume":"59","author":"Yang","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.radonc.2026.111366_b0280","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2017.06.017","article-title":"Silencing HIF-1\u03b1 induces TET2 expression and augments ascorbic acid induced 5-hydroxymethylation of DNA in human metastatic melanoma cells","volume":"490","author":"Fischer","year":"2017","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:21:51Z","timestamp":1781511711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"alternative-id":["S0167814026000046"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111366","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A seven-gene 5-hydroxymethylcytosine signature in circulating cell-free DNA for prognostic stratification of nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111366"}}